欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/5462/001
药品名称Gaviscon Double Action Mixed Berries Flavour Chewable Tablets
活性成分
    • calcium carbonate 187.5 mg
    • sodium alginate 250.0 mg
    • sodium bicarbonate 106.5 mg
剂型Chewable tablet
上市许可持有人Reckitt Benckiser Healthcare B.V. Siriusdreef 14 2132 WT Hoofddorp
参考成员国 - 产品名称Netherlands (NL)
Gaviscon Duo Bosvruchtensmaak 250 mg /106,5 mg/187,5 mg, kauwtabletten
互认成员国 - 产品名称
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Gaviscon 250 mg/106,5 mg/ 187,5 mg kramtomosios tabletės
    • Estonia (EE)
    • Hungary (HU)
    • Denmark (DK)
    • Bulgaria (BG)
      Gaviscon Double Action Mixed Raspberry Flavour
    • Iceland (IS)
    • Romania (RO)
    • Austria (AT)
    • France (FR)
    • Portugal (PT)
    • Norway (NO)
    • Finland (FI)
      Garbalieve purutabletti mixed berries
许可日期2023/08/02
最近更新日期2024/04/11
药物ATC编码
    • A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Non Prescription (including OTC)
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase